Page 92 - EASL POSTGRADUATE COURSE
P. 92
histological severity of nonalcoholic fatty liver disease. Am J Gastroenterol 2011;106:460-468; quiz
469.
[13] Trichopoulou A, Costacou T, Bamia C, et al. Adherence to a Mediterranean diet and survival in a
Greek population. N Engl J Med 2003;348:2599-2608.
[14] Li WQ, ParkY, McGlynn KA, et al. Index-based dietary patterns and risk of incident hepatocellular
carcinoma and mortality from chronic liver disease in a prospective study. Hepatology 2014;60:588-
597.
[15] Kontogianni MD, Tileli N, Margariti A, et al. Adherence to the Mediterranean diet is associated
with the severity of non-alcoholic fatty liver disease. Clin Nutr 2014;33:678-683.
[16] Ryan MC, Itsiopoulos C, Thodis T, et al. The Mediterranean diet improves hepatic steatosis and
insulin sensitivity in individuals with non-alcoholic fatty liver disease. J Hepatol 2013;59:138-143.
[17] Abdelmalek MF, Suzuki A, Guy C, et al. Increased fructose consumption is associated with fibrosis
severity in patients with nonalcoholic fatty liver disease. Hepatology 2010;51:1961-1971.
[18] Maersk M, Belza A, Stodkilde-Jorgensen H, et al. Sucrose-sweetened beverages increase fat storage
in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study. Am J Clin Nutr
2012;95:283-289.
[19] O’Sullivan TA, Oddy WH, Bremner AP, et al. Lower fructose intake may help protect against
development of nonalcoholic fatty liver in adolescents with obesity. J Pediatr Gastroenterol Nutr
2014;58:624-631.
[20] Musso G, Olivetti C, Cassader M, Gambino R. Obstructive sleep apnea-hypopnea syndrome and
nonalcoholic fatty liver disease: emerging evidence and mechanisms. Semin Liver Dis 2012;32:49-
64.
[21] Kim CW, Yun KE, Jung HS, Chang Y, Choi ES, Kwon MJ, et al. Sleep duration and quality in
relation to non-alcoholic fatty liver disease in middle-aged workers and their spouses. J Hepatol
2013;59:351-357.
[22] Musso G, Cassader M, Olivetti C, Rosina F, Carbone G, Gambino R. Association of obstructive
sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review
and meta-analysis. Obes Rev 2013;14:417-431.
[23] Doyle C, Kushi LH, ByersT, et al. Nutrition and physical activity during and after cancer treatment:
an American Cancer Society guide for informed choices. CA Cancer J Clin 2006;56:323-353.
[24] Schmitz KH, Courneya KS, Matthews C, et al. American College of Sports Medicine roundtable
on exercise guidelines for cancer survivors. Med Sci Sports Exerc 2010;42:1409-1426.
[25] WCRF/AICR. Food, Nutrition and the Prevention of Cancer: A Global Persepctive Expert Report;
2007.
[26] Pekmezi DW, Demark-WahnefriedW. Updated evidence in support of diet and exercise interventions
in cancer survivors. Acta Oncol 2011;50:167-178.
[27] Nishikawa H, OsakiY, Takeda H, et al. Effect of body mass index on survival after curative therapy
for non-B non-C hepatocellular carcinoma. J Gastrointestin Liver Dis 2013;22:173-181.
[28] Poggiogalle E, Migliaccio S, Lenzi A, et al. Treatment of body composition changes in obese and
overweight older adults: insight into the phenotype of sarcopenic obesity. Endocrine 2014;47:699-
716.
[29] Turati F, Trichopoulos D, Polesel J, et al. Mediterranean diet and hepatocellular carcinoma. J
Hepatol 2014;60:606-611.
[30] Freedman ND, Cross AJ, McGlynn KA, et al. Association of meat and fat intake with liver disease
and hepatocellular carcinoma in the NIH-AARP cohort. J Natl Cancer Inst 2010;102:1354-1365.
[31] Saab S, Mallam D, Cox GA, 2nd, et al. Impact of coffee on liver diseases: a systematic review. Liver
Int 2014;34:495-504.
[32] Goh GB, Chow WC, Wang R, et al. Coffee, alcohol and other beverages in relation to cirrhosis
mortality: the Singapore Chinese Health Study. Hepatology 2014;60:661-669.
[33] Zelber-Sagi S, Salomone F, Webb M, et al. Coffee consumption and nonalcoholic fatty liver onset:
a prospective study in the general population.Transl Res 2014; doi: 10.1016/j.trsl.2014.10.008.
92 Postgraduate Course Syllabus • Metabolic Liver Disease
469.
[13] Trichopoulou A, Costacou T, Bamia C, et al. Adherence to a Mediterranean diet and survival in a
Greek population. N Engl J Med 2003;348:2599-2608.
[14] Li WQ, ParkY, McGlynn KA, et al. Index-based dietary patterns and risk of incident hepatocellular
carcinoma and mortality from chronic liver disease in a prospective study. Hepatology 2014;60:588-
597.
[15] Kontogianni MD, Tileli N, Margariti A, et al. Adherence to the Mediterranean diet is associated
with the severity of non-alcoholic fatty liver disease. Clin Nutr 2014;33:678-683.
[16] Ryan MC, Itsiopoulos C, Thodis T, et al. The Mediterranean diet improves hepatic steatosis and
insulin sensitivity in individuals with non-alcoholic fatty liver disease. J Hepatol 2013;59:138-143.
[17] Abdelmalek MF, Suzuki A, Guy C, et al. Increased fructose consumption is associated with fibrosis
severity in patients with nonalcoholic fatty liver disease. Hepatology 2010;51:1961-1971.
[18] Maersk M, Belza A, Stodkilde-Jorgensen H, et al. Sucrose-sweetened beverages increase fat storage
in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study. Am J Clin Nutr
2012;95:283-289.
[19] O’Sullivan TA, Oddy WH, Bremner AP, et al. Lower fructose intake may help protect against
development of nonalcoholic fatty liver in adolescents with obesity. J Pediatr Gastroenterol Nutr
2014;58:624-631.
[20] Musso G, Olivetti C, Cassader M, Gambino R. Obstructive sleep apnea-hypopnea syndrome and
nonalcoholic fatty liver disease: emerging evidence and mechanisms. Semin Liver Dis 2012;32:49-
64.
[21] Kim CW, Yun KE, Jung HS, Chang Y, Choi ES, Kwon MJ, et al. Sleep duration and quality in
relation to non-alcoholic fatty liver disease in middle-aged workers and their spouses. J Hepatol
2013;59:351-357.
[22] Musso G, Cassader M, Olivetti C, Rosina F, Carbone G, Gambino R. Association of obstructive
sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review
and meta-analysis. Obes Rev 2013;14:417-431.
[23] Doyle C, Kushi LH, ByersT, et al. Nutrition and physical activity during and after cancer treatment:
an American Cancer Society guide for informed choices. CA Cancer J Clin 2006;56:323-353.
[24] Schmitz KH, Courneya KS, Matthews C, et al. American College of Sports Medicine roundtable
on exercise guidelines for cancer survivors. Med Sci Sports Exerc 2010;42:1409-1426.
[25] WCRF/AICR. Food, Nutrition and the Prevention of Cancer: A Global Persepctive Expert Report;
2007.
[26] Pekmezi DW, Demark-WahnefriedW. Updated evidence in support of diet and exercise interventions
in cancer survivors. Acta Oncol 2011;50:167-178.
[27] Nishikawa H, OsakiY, Takeda H, et al. Effect of body mass index on survival after curative therapy
for non-B non-C hepatocellular carcinoma. J Gastrointestin Liver Dis 2013;22:173-181.
[28] Poggiogalle E, Migliaccio S, Lenzi A, et al. Treatment of body composition changes in obese and
overweight older adults: insight into the phenotype of sarcopenic obesity. Endocrine 2014;47:699-
716.
[29] Turati F, Trichopoulos D, Polesel J, et al. Mediterranean diet and hepatocellular carcinoma. J
Hepatol 2014;60:606-611.
[30] Freedman ND, Cross AJ, McGlynn KA, et al. Association of meat and fat intake with liver disease
and hepatocellular carcinoma in the NIH-AARP cohort. J Natl Cancer Inst 2010;102:1354-1365.
[31] Saab S, Mallam D, Cox GA, 2nd, et al. Impact of coffee on liver diseases: a systematic review. Liver
Int 2014;34:495-504.
[32] Goh GB, Chow WC, Wang R, et al. Coffee, alcohol and other beverages in relation to cirrhosis
mortality: the Singapore Chinese Health Study. Hepatology 2014;60:661-669.
[33] Zelber-Sagi S, Salomone F, Webb M, et al. Coffee consumption and nonalcoholic fatty liver onset:
a prospective study in the general population.Transl Res 2014; doi: 10.1016/j.trsl.2014.10.008.
92 Postgraduate Course Syllabus • Metabolic Liver Disease
